{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:35Z","timestamp":1791286955618,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"37-38","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.07.016","type":"journal-article","created":{"date-parts":[[2007,7,28]],"date-time":"2007-07-28T07:10:16Z","timestamp":1185606616000},"page":"6661-6671","source":"Crossref","is-referenced-by-count":15,"title":["Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE)"],"prefix":"10.1016","volume":"25","author":[{"given":"Konstantin V.","family":"Pugachev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon W.","family":"Ocran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Rumyantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Khromykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Guirakhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.07.016_bib1","series-title":"Fields virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.vaccine.2007.07.016_bib2","series-title":"Fields virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.vaccine.2007.07.016_bib3","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric virus: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.07.016_bib5","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib6","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/viro.2002.1462","article-title":"Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates","volume":"298","author":"Guirakhoo","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.07.016_bib8","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.016_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.016_bib11","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.07.016_bib12","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0020-7519(03)00063-8","article-title":"Traditional and novel approaches to flavivirus vaccines","volume":"33","author":"Pugachev","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib14","series-title":"New generation vaccines","first-page":"559","article-title":"Chimeric vaccines against Japanese encephalitis, dengue, and West Nile","author":"Pugachev","year":"2004"},{"key":"10.1016\/j.vaccine.2007.07.016_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.016_bib16","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(04)16459-3","article-title":"Live flavivirus vaccines: reasons for caution","volume":"363","author":"Seligman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(04)16802-5","article-title":"Arguments for live flavivirus vaccines","volume":"364","author":"de Silva","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(04)16801-3","article-title":"Arguments for live flavivirus vaccines","volume":"364","author":"Murphy","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(04)16800-1","article-title":"Arguments for live flavivirus vaccines","volume":"364","author":"Hombach","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib20","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.vaccine.2004.11.069","article-title":"Recombination and flavivirus vaccines: a commentary","volume":"23","author":"Monath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.016_bib21","series-title":"Vaccines","first-page":"651","article-title":"Poliovirus vaccine\u2014live","author":"Sutter","year":"2004"},{"key":"10.1016\/j.vaccine.2007.07.016_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.molbev.a026121","article-title":"Phylogenetic evidence for recombination in dengue virus","volume":"16","author":"Holmes","year":"1999","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib23","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1073\/pnas.96.13.7352","article-title":"Widespread intraserotype recombination in natural populations of dengue virus","volume":"96","author":"Worobey","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.07.016_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/vir.0.18660-0","article-title":"The extent of homologous recombination in members of the genus Flavivirus","volume":"84","author":"Twiddy","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/viro.2002.1686","article-title":"Diversity and evolution of the envelope gene of dengue virus type 1","volume":"303","author":"Goncalvez","year":"2002","journal-title":"Virology"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2007.07.016_bib26","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.07.016_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2007.07.016_bib28","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1128\/JVI.77.14.7804-7813.2003","article-title":"Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication","volume":"77","author":"Liu","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0264-410X(01)00439-X","article-title":"Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing","volume":"20","author":"Pugachev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.016_bib30","unstructured":"National Research Council. Guide for the care and use of laboratory animals. Washington: National Academy Press; 1996."},{"key":"10.1016\/j.vaccine.2007.07.016_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/viro.1999.9956","article-title":"Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1","volume":"264","author":"Hall","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.07.016_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.016_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.010420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.016_bib34","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.07.016_bib35","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.07.016_bib36","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"Khromykh","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/viro.2000.0748","article-title":"Genetic variation in the 3\u2032 non-coding region of dengue viruses","volume":"281","author":"Shurtleff","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.07.016_bib38","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JVI.77.3.2265-2270.2003","article-title":"Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization","volume":"77","author":"Corver","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib39","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.79.11.6631-6643.2005","article-title":"Long-range RNA-RNA interactions circularize the dengue virus genome","volume":"79","author":"Alvarez","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib41","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.vaccine.2007.07.016_bib42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2000.62.480","article-title":"Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF\/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes","volume":"62","author":"Bhatt","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.07.016_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2006.75.659","article-title":"Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever\/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE)","volume":"75","author":"Reid","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.07.016_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.2002.67.260","article-title":"Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes","volume":"67","author":"Johnson","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.07.016_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2915.2003.00438.x","article-title":"Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes","volume":"17","author":"Johnson","year":"2003","journal-title":"Med Vet Entomol"},{"key":"10.1016\/j.vaccine.2007.07.016_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2004.70.89","article-title":"Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus ixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction","volume":"70","author":"Johnson","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.07.016_bib47","doi-asserted-by":"crossref","unstructured":"Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998. Vaccine 2000;18(Suppl. 2):1\u201325.","DOI":"10.1016\/S0264-410X(00)00037-2"},{"key":"10.1016\/j.vaccine.2007.07.016_bib48","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.016_bib50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/14712598.4.8.1295","article-title":"West Nile virus vaccines","volume":"4","author":"Hall","year":"2004","journal-title":"Expert Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T08:31:41Z","timestamp":1587803501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":50,"journal-issue":{"issue":"37-38","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0264410X07007979"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}